Executive Summary 5 Indonesia Pharmaceutical Industry SWOT 6 Indonesia Political SWOT 7 Indonesia Economic SWOT 7 Indonesia Business Environment SWOT 8 Indonesia: Business Environment Ranking9 Table: Asia Business Environment Rankings 9 Business Environment Ranking 10 Economics - Long-Term Risk 10 Politics - Long-Term Risk 10 Regulatory Barriers 10 Domestic Sector Threat 10 Market Growth Potential 11 Market Size Ranking 11 Indonesia: Market Ov12 Regulatory Regime13 Pricing And Reimbursement Regimes 17 Price Cuts 17 Industry Trends And Developments 20 Table: Bayer Consumer Care Products Available In Indonesia 21 Epidemiology 21 Avian Flu 22 Healthcare System 23 Pharmaceutical Sector 24 Retail Sector 25 Research & Development (R&D) 26 Table: Clinical Trial Considerations In Asia 26 Industry Forecast Scenario 27 Overall Market Forecast 27 Table: Indonesia Pharmaceutical Market Indicators 28 Key Growth Factors - Industry 29 Table: Indonesia Health Expenditure Forecasts 30 Key Growth Factors - Macroeconomic 31 Table: GDP And Population 33 Prescription Market Forecast 34 Table: Indonesia Prescription Drug Market Forecast 35 OTC Market Forecast 36 Table: Indonesia OTC Market Forecasts 37 Generics And Branded Market Forecast 38 Table: Indonesia Generics and Branded Market Forecasts 39 Export/Import Forecast 40 Table: Indonesia Pharmaceutical Trade Forecasts 41 Other Healthcare Data And Forecasts 42 Table: Indonesia Other Health Indicators 42 Key Risks To our Forecast Scenario 42 Competitive Landscape43 Company Monitor44 Profiles: Leading Foreign Manufacturers 44 Sanofi-Aventis 44 Pfizer 46 Novartis 48 GlaxoSmithKline 50 Merck & Co 52 Indigenous Manufacturers 53 PT Kalbe Farma 53 PT Bio Farma 58 Kimia Pharma 60 PT SidoMuncul 62 Combiphar PT 63 Darya-Varia 64 BMI Forecast Modelling66 How We Generate Our Industry Forecasts 66 Technical Process 66 Pharmaceutical Industry 67 Sources 67
